Pediatrics

Our broad testing capabilities are backed by the deep expertise of ARUP’s specialists and subspecialists, who understand the challenges of diagnosing childhood diseases.

Children with rare diseases often face long diagnostic odysseys. ARUP’s advanced testing enables a more straightforward pathway to diagnosis.

• Rapid Genome Sequencing (3019947)
  ARUP’s rapid whole genome sequencing (rWGS) assay yields results within 3 to 7 days, providing clear, rapid answers for patients with acute conditions, including newborns in the neonatal intensive care unit.

From the most routine bacterial cultures to advanced molecular methods, our frontline testing ensures accurate, timely care for children. Our menu continually evolves to meet emerging clinical needs.

• Measles Virus by Qualitative NAAT (3019269) 
  As the first commercially available reference test that both detects the measles virus and distinguishes between vaccine-related and wild-type strains of the virus, ARUP’s dual-target molecular measles virus assay provides a highly sensitive, specific, and rapid test to aid the public health response to measles outbreaks.

Our broad range of tests captures every aspect of the disease landscape, empowering you to target pediatric cancers with tailored treatment strategies. As a laboratory certified by the Chidren’s Oncology Group (COG), ARUP has rigorous standards and delivers results you can trust.

• B-Lymphoblastic Leukemia (B-ALL) Minimum Residual Disease Detection by Flow Cytometry (3000724) 
  Minimal residual disease (MRD) findings provide crucial insights for disease prognosis and treatment decisions. ARUP’s test provides a highly sensitive and cost-effective method to detect B-ALL MRD that doesn’t require sequencing of the original tumor.

At ARUP, we understand the unique challenges of diagnosing neurologic conditions in pediatric patients. Our pediatric neurology testing is designed to support clinicians with accurate, timely, and clinically relevant results.

• Autoimmune Pediatric Central Nervous System (CNS) Disorders (3006210) and (3006211) 
  ARUP’s phenotype-targeted panels test for the presence of antibodies associated with pediatric autoimmune encephalopathy, epilepsy, behavior changes, and movement disorders.

ARUP supports newborn screening programs by confirming abnormal results and promoting early diagnosis, ensuring inherited conditions such as guanidinoacetate methyltransferase (GAMT) deficiency are identified and treated before they affect a child’s health.

• Creatine Disorders Panel, Serum or Plasma (2002328) 
  ARUP’s assay to detect creatine deficiency syndromes aids in the diagnosis of GAMT deficiency, a condition for which early detection and relatively simple treatments can dramatically change the lives of patients who are affected.
• Autism and Intellectual Disability Comprehensive Panel (2014314) 
  ARUP’s comprehensive panel includes recommended first-tier testing for autism spectrum disorders and intellectual disability, providing comprehensive and highly accurate results to aid in decisions about treatment and management.

Our comprehensive drug detection panels detect a range of substances. ARUP analyzes specimens by mass spectrometry up front, providing specific, accurate results from the beginning and eliminating unnecessary testing.

• Drug Detection Panel, Umbilical Cord Tissue, Qualitative (2006621) 
  ARUP’s drug detection assay performed on umbilical cord tissue facilitates easier collection and provides timely answers to initiate treatment for newborns experiencing withdrawal symptoms. The assay reports more than 50 of the most used drugs and drug metabolites.

ARUP’s Cytogenetics Laboratory understands that every sample represents a patient, and our genetic counselors and specialists devote meticulous attention to each case to ensure optimal patient care. Our wide variety of sample types and fluorescence in situ hybridization (FISH) probes allows you to tailor testing to meet the needs of your patient.

• Chromosome Analysis, Constitutional Blood, with Reflex to Genomic Microarray (2005763)
  ARUP’s comprehensive cytogenetics testing includes a broad range of tests performed on a wide array of sample types. Our single-site operation and convenient reflex testing support optimal patient care and efficient turnaround times while minimizing costs.